kabutan

Nippon Shinyaku Co.,Ltd.(4516) Summary

4516
TSE Prime
Nippon Shinyaku Co.,Ltd.
5,472
JPY
+60
(+1.11%)
Mar 13, 3:30 pm JST
34.32
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
5,500
Mar 13, 8:37 pm JST
Summary Chart Historical News Financial Result
PER
14.0
PBR
1.30
Yield
2.27%
Margin Trading Ratio
6.79
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
5,344 JPY 33.56 USD
Previous Close Mar 12
5,412 JPY 34.04 USD
High Mar 13, 9:16 am
5,499 JPY 34.57 USD
Low Mar 13, 9:00 am
5,329 JPY 33.46 USD
Volume
391,300
Trading Value
2.13B JPY 0.01B USD
VWAP
5442.59 JPY 34.14 USD
Minimum Trading Value
547,200 JPY 3,432 USD
Market Cap
0.38T JPY 2.42B USD
Number of Trades
1,489
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,462
1-Year High Dec 8, 2025
46,428
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 10,900 94,500 8.67
Feb 27, 2026 35,300 92,000 2.61
Feb 20, 2026 22,200 91,300 4.11
Feb 13, 2026 28,300 94,300 3.33
Feb 6, 2026 31,200 100,400 3.22
Company Profile
Nippon Shinyaku Co., Ltd. primarily focuses on prescription pharmaceuticals, with strengths in urology and cardiovascular fields. The company also operates in the functional food business.
Sector
Pharmaceuticals
Nippon Shinyaku Co., Ltd. centers its operations on the pharmaceutical business, primarily targeting medical professionals, while also expanding into the functional food sector. In the pharmaceutical business, the company manufactures and sells its own products, and its subsidiary, Sioe Pharmaceutical Co., Ltd., also engages in manufacturing and sales. Tajima Food Co., Ltd. manufactures raw materials and supplies them to Nippon Shinyaku. Overseas, the U.S. subsidiary is responsible for pharmaceutical sales, out-licensing, and clinical development, while the Chinese subsidiary provides business support and sales services. In the functional food business, Nippon Shinyaku manufactures and sells its own products, with Tajima Food Co., Ltd. handling contract manufacturing. The company also receives product supplies from Sioe Pharmaceutical Co., Ltd. Furthermore, the subsidiary Nippon Shinyaku Advance Co., Ltd. provides business support, insurance agency services, real estate leasing, and educational support services.